Unimax Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-01-2025
- Paid Up Capital ₹ 7.00 M
as on 10-01-2025
- Company Age 40 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.75 Cr
as on 10-01-2025
- Revenue 34.10%
(FY 2022)
- Profit 62.63%
(FY 2022)
- Ebitda 20.45%
(FY 2022)
- Net Worth 26.69%
(FY 2022)
- Total Assets 22.24%
(FY 2022)
About Unimax Laboratories
The Corporate was formerly known as Eastern Remedies P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹6.75 Cr.
Kaushik Shah, Piyush Shah, Brijesh Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH1985PTC035004
- Company No.
035004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unimax Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Shah  | Managing Director | 01-Jul-1985 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Shah | Director | 01-Jul-1999 | Current |
| Brijesh Shah | Director | 01-Jul-1999 | Current |
| Anil Ghogare | Director | 02-May-2005 | Current |
Financial Performance of Unimax Laboratories.
Unimax Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.1% increase. The company also saw a substantial improvement in profitability, with a 62.63% increase in profit. The company's net worth Soared by an impressive increase of 26.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimax Laboratories?
In 2022, Unimax Laboratories had a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unimax Chemicals Private LimitedActive 39 years 8 monthsKaushik Shah, Piyush Shah and 1 more are mutual person
Charges (Loans)
₹6.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 6.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2006 | Bank Of Baroda | ₹3.05 Cr | Open |
| 06 Sep 2006 | Bank Of Baroda | ₹3.70 Cr | Open |
How Many Employees Work at Unimax Laboratories?
Unimax Laboratories has a workforce of 12 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimax Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
